Charlie Barker Named Director Of Scientific Services At SNBL USA

EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA, the experts in preclinical research, today announced Charlie Barker has joined the executive team to serve as the Director of Scientific Services. In this position Charlie will assume leadership for all scientific technical service activities and associated personnel. He will implement and execute strategic plans, policies, and procedures to ensure SNBL USA's toxicology services meet or exceed clients' needs, timelines, quality, and regulatory requirements.

"Charlie's experience and wide range of technical expertise in the industry positions him as an ideal catalyst to help guide SNBL USA to the next level of excellence in our preclinical service offerings."

"We are excited to have Charlie on board to provide strategic direction to the scientific services team," said Steve Glaza, SNBL USA chief operating officer. "Charlie's experience and wide range of technical expertise in the industry positions him as an ideal catalyst to help guide SNBL USA to the next level of excellence in our preclinical service offerings."

Charlie Barker has over 22 years industry experience in the toxicology field, including government research laboratories, and is well-versed in many areas of the drug development process. Prior to joining SNBL USA, he has held various positions including senior director of technical operations at WuXi AppTec, operations manager at Charles River, and animal care specialist as a member of the Army Veterinary Corps with assignments at Walter Reed Army Institute of Research, the Naval Medical Research Institute and Tripler Army Medical Center. Mr. Barker holds a Bachelor of Science degree in Biomedical Science from Crown University and is an AALAS-certified Laboratory Animal Technician. Charlie has a strong background in developing successful training programs that produce highly qualified, motivated technical staffs and mentoring staff members in career development.

For additional information regarding SNBL USA services and capabilities, contact us at +1.425.322.1950 or [email protected]

About SNBL USA, Ltd.

Headquartered in Everett, Wash., SNBL USA, Ltd. offers a unique range of safety assessment services to fulfill its commitment to help free patients from suffering. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, SNBL USA offers programs ranging from regulatory toxicology to customized study designs in multiple drug classes (biologics, small molecules, oligonucleotides, vaccines, gene therapy).

SNBL USA, Ltd.
Michelle Taylor, MA, 425-322-1950
Marketing Manager
[email protected]

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.